Genetic Technologies Limited (ASX:GTG)

0.6¢

right-arrow Created with Sketch. 0 (0%)
MCAP $55.40M
Last trade 15.13pm 26/11/2021 20mins delayed

Latest Announcements

24/11/2021GTGGenetic Technologies Limited
24/11/2021GTGGenetic Technologies Limited
24/11/2021GTGGenetic Technologies Limited
09/11/2021GTGGenetic Technologies Limited
09/11/2021GTGGenetic Technologies Limited
04/11/2021GTGGenetic Technologies Limited
187
MCap
03/11/2021GTGGenetic Technologies Limited
03/11/2021GTGGenetic Technologies Limited

Company Overview

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company focuses on the development and commercialization of genetic risk assessment technology for contracting cancer and other chronic diseases. The Company operates through two geographic segments: Australia and United states of America (USA). Australia segment is the home country of the parent entity and the location of the Company's genetic testing and licensing operations. USA segment is the home of Phenogen Sciences Inc. and GeneType Corporation. The Company’s products include GeneType for Breast Cancer is a test that can determine a woman's risk of developing sporadic breast cancer over a period of time; GeneType for Colorectal Cancer is a test that can determine a patient's risk of developing colorectal cancer over a period of time. The Company focuses on development its Germline testing division for hereditary testing.

GTG in the news

Genetic Technologies (GTG) acquires EasyDNA for around $5.4 million in cash and…
Genetic Technologies (GTG) has officially launched its COVID-19 Serious Disease Risk Test…
Genetic Technologies (GTG) has signed a three-year agreement with Infinity BiologiX to…
Genetic Technologies (GTG) has entered into a conditional agreement to procure US$6.6…

Search Previous Announcements